Addition of intramuscular progesterone to vaginal progesterone in hormone replacement therapy in vitrified-warmed blastocyst transfer cycles

Polat, Mehtap; MÜMÜŞOĞLU, SEZCAN; BOZDAĞ, GÜRKAN; Ozbek, Irem; Humaidan, Peter; Yarali, Hakan

doi:10.1016/j.rbmo.2020.01.0311472-6483

Addition of intramuscular progesterone to vaginal progesterone in hormone replacement therapy in vitrified-warmed blastocyst transfer cycles

Atıf İçin Kopyala

Polat M., MÜMÜŞOĞLU S., BOZDAĞ G., Ozbek I. Y., Humaidan P., Yarali H.

REPRODUCTIVE BIOMEDICINE ONLINE, cilt.40, sa.6, ss.812-818, 2020 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 40 Sayı: 6
Basım Tarihi: 2020
Doi Numarası: 10.1016/j.rbmo.2020.01.0311472-6483
Dergi Adı: REPRODUCTIVE BIOMEDICINE ONLINE
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE, MEDLINE
Sayfa Sayıları: ss.812-818
Anahtar Kelimeler: Cryopreserved embryo transfer, Hormone replacement therapy, Im progesterone supplementation, IVF, Serum progesterone, Vaginal progesterone supplementation, SERUM PROGESTERONE, EMBRYO-TRANSFER, IMPLANTATION, ENDOMETRIN, RATES
Hacettepe Üniversitesi Adresli: Evet

Özet

Research question: Does intramuscular progesterone supplementation ensure ongoing pregnancy rates (OPR) comparable with vaginal progesterone only in hormone replacement therapy cycles for vitrified-warmed embryo transfer; and is there a window of serum progesterone concentration out of which reproductive outcomes may be negatively affected?